Quo vadis autoimmune hepatitis? - Summary of the 5th international autoimmune hepatitis group research workshop 2024Keypoints
Summary: Autoimmune hepatitis (AIH) is a rare chronic liver disease with an increasing incidence in many countries. Chronic autoimmune responses against the liver can cause hepatic and extrahepatic symptoms, decreased quality of life and reduced liver transplant-free survival if inadequately treated...
Saved in:
Main Authors: | Bastian Engel, David N. Assis, Mamatha Bhat, Jan Clusmann, Joost PH. Drenth, Alessio Gerussi, María-Carlota Londoño, Ye Htun Oo, Ida Schregel, Marcial Sebode, Richard Taubert |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-02-01
|
Series: | JHEP Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2589555924002696 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Genetically Engineered Islets and Alternative Sources of Insulin-Producing Cells for Treating Autoimmune Diabetes: Quo Vadis?
by: Feng-Cheng Chou, et al.
Published: (2012-01-01) -
Quo Vadis Pilkada Indonesia
by: Wira Atma Hajri
Published: (2017-10-01) -
Seronegative autoimmune hepatitis
by: A. O. Buyeverov
Published: (2018-08-01) -
European Monetary Union: Euro — Quo vadis?
by: Jens Hölscher
Published: (2020-09-01) -
QUO VADIS DREPTURILE OMULUI ÎN EUROPA?
by: USM ADMIN
Published: (2025-01-01)